Cargando…

Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor

Synthesis and evaluation of new scaffold phenylisoserine derivatives connected with the essential functional groups against SARS CoV 3CL protease are described. The phenylisoserine backbone was found by simulation on GOLD software and the structure activity relationship study of phenylisoserine deri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Konno, Hiroyuki, Onuma, Takumi, Nitanai, Ikumi, Wakabayashi, Masaki, Yano, Shigekazu, Teruya, Kenta, Akaji, Kenichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127027/ https://www.ncbi.nlm.nih.gov/pubmed/28454669 http://dx.doi.org/10.1016/j.bmcl.2017.04.056

Ejemplares similares

Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
por: Konno, Hiroyuki, et al.
Publicado: (2016)

Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
por: Shimamoto, Yasuhiro, et al.
Publicado: (2015)

Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant
por: Akaji, Kenichi, et al.
Publicado: (2008)

Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease
por: Akaji, Kenichi, et al.
Publicado: (2020)

Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor
por: Yoshizawa, Shin-ichiro, et al.
Publicado: (2020)

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
por: Konno, Sho, et al.
Publicado: (2013)

The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
por: Awahara, Chiyuki, et al.
Publicado: (2022)

Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
por: Thanigaimalai, Pillaiyar, et al.
Publicado: (2013)

Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
por: Thanigaimalai, Pillaiyar, et al.
Publicado: (2013)

Phenylisoserine in the gas-phase and water: Ab initio studies on neutral and zwitterion conformers
por: Rode, Joanna E., et al.
Publicado: (2010)

Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor
por: Ohnishi, Kouji, et al.
Publicado: (2019)

Practical synthesis of peptide C-terminal aldehyde on a solid support
por: Konno, Hiroyuki, et al.
Publicado: (2013)

Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease
por: Ramajayam, R., et al.
Publicado: (2010)

Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
por: Shao, Yi-Ming, et al.
Publicado: (2008)

Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors
por: Chen, Li-Rung, et al.
Publicado: (2005)

Plant Products as Inhibitors of Coronavirus 3CL Protease
por: Mandal, Anirban, et al.
Publicado: (2021)

Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety
por: Zhu, Mengwei, et al.
Publicado: (2023)

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2020)

Evaluation of metal‐conjugated compounds as inhibitors of 3CL protease of SARS‐CoV
por: Hsu, John T.-A., et al.
Publicado: (2004)

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021)

Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitors
por: Sydnes, Magne O., et al.
Publicado: (2006)

α-1,3-Glucanase from the gram-negative bacterium Flavobacterium sp. EK-14 hydrolyzes fungal cell wall α-1,3-glucan
por: Takahashi, Masaki, et al.
Publicado: (2023)

Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease
por: Liu, Yu-Chih, et al.
Publicado: (2005)

Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?
por: Hamada, Yohei, et al.
Publicado: (2013)

In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
por: Maulana, Saipul, et al.
Publicado: (2023)

Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021)

An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease
por: Zhai, Tianhua, et al.
Publicado: (2021)

Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL(pro)
por: Ma, Ling, et al.
Publicado: (2022)

Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally
por: Kawashima, Sho, et al.
Publicado: (2023)

A simplified cell-based assay to identify coronavirus 3CL protease inhibitors
por: Resnick, Samuel J., et al.
Publicado: (2020)

Inhibition of SARS-CoV 3CL protease by flavonoids
por: Jo, Seri, et al.
Publicado: (2019)

The Hydrophobicity and Antifungal Potentiation of Burkholdine Analogues
por: Konno, Hiroyuki, et al.
Publicado: (2022)

Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
por: Zhu, Wei, et al.
Publicado: (2020)

Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening
por: Zhu, Wei, et al.
Publicado: (2020)

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Su, Haixia, et al.
Publicado: (2021)

In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
por: Xiong, Muya, et al.
Publicado: (2022)

Synthesis and Biochemical Evaluation of 8H-Indeno[1,2-d]thiazole Derivatives as Novel SARS-CoV-2 3CL Protease Inhibitors
por: Wu, Jing, et al.
Publicado: (2022)

Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease
por: Jia, Ze-jun, et al.
Publicado: (2023)

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
por: Boras, Britton, et al.
Publicado: (2021)

Mechanism of the Maturation Process of SARS-CoV 3CL Protease
por: Hsu, Min-Feng, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_mqo9586lqnqe3vgu3f021ihb3a